BIOFLOR

This brand name is authorized in Cyprus, Hong Kong SAR China, Malta, Nigeria, Singapore.

Active ingredients

The drug BIOFLOR contains one active pharmaceutical ingredient (API):

1	Saccharomyces boulardii CNCM I-745 UNII 978D8U419H - SACCHAROMYCES CEREVISIAE
	Saccharomyces boulardii is an intestinal flora replacement which acts as antidiarrheal microorganisms in the digestive tract. During transit under its viable form in the digestive tract, saccharomyces boulardii exerts biological actions which are similar to the protective properties of the normal intestinal flora.
	Read more about Saccharomyces boulardii

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BIOFLOR Powder for oral suspension	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
BIOFLOR Capsule, hard	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07FA02	Saccharomyces boulardii	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms
Discover more medicines within A07FA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	30568, 41663
MT	Medicines Authority	MA239/00101, MA239/00102, MA239/00103
NG	Registered Drug Product Database	A4-5491
Switch country to Nigeria in order to find specific presentations of BIOFLOR
SG	Health Sciences Authority	14722P, 14986P